NCT06580158

Brief Summary

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Nov 2024Mar 2027

First Submitted

Initial submission to the registry

August 29, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

November 8, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

March 4, 2026

Status Verified

January 1, 2026

Enrollment Period

2.3 years

First QC Date

August 29, 2024

Last Update Submit

March 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of patients with positive AI-ECG

    Positive AI-ECG will be determined by the sensitivity, specificity, positive predictive value, and negative predictive value.

    Baseline

  • Number of studies with reasonable image quality in patients with positive AI-ECG

    Image quality will be determined by sonographers at the time of imaging and will be scored on a scale from 1-4: 1. Excellent , sufficient for publication 2. Good, sufficient for data analysis 3. Fair, just enough for data analysis without complete views 4. Poor, not usable for data analysis

    Baseline

Secondary Outcomes (1)

  • Number of times the AI ECG and TTE (transthoracic echocardiogram) are statistically comparative

    Baseline

Study Arms (1)

Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

Device: AI-ECG DashboardDiagnostic Test: Point of care ultrasound (POCUS)

Interventions

Patients standard of care ECG's will be processed through the AI-ECG Dashboard

Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

Patients will undergo a ultrasound to confirm diagnosis of atrial stenosis or diastolic dysfunction.

Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

You may qualify if:

  • ≥ 60 years of age must have a clinical scheduled ECG performed.

You may not qualify if:

  • \< 59 years of age
  • Is not scheduled for a clinical ECG
  • Unable to provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

RECRUITING

MeSH Terms

Conditions

Aortic Valve Stenosis

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Officials

  • Jae Oh, M.D.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jae Oh, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 29, 2024

First Posted

August 30, 2024

Study Start

November 8, 2024

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

March 4, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations